Skip to main content
OSE Immunotherapeutics SA (EPA:OSE)
France flag France · Delayed Price · Currency is EUR
4.250
+0.592 (16.18%)
Apr 28, 2026, 5:35 PM CET

OSE Immunotherapeutics Revenue

In the year 2025, OSE Immunotherapeutics had annual revenue of 1.78M EUR, down -97.86%. OSE Immunotherapeutics had revenue of 862.00K in the half year ending December 31, 2024, a decrease of -61.77%.

Revenue
1.78M
Revenue Growth
-95.84%
P/S Ratio
53.47
Revenue / Employee
27.84K
Employees
64
Market Cap
95.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.78M-81.65M-97.86%
Dec 31, 202483.44M81.21M3,646.52%
Dec 31, 20232.23M-16.08M-87.83%
Dec 31, 202218.30M-8.00M-30.43%
Dec 31, 202126.31M15.89M152.48%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Valerio Therapeutics Société anonyme 1.83M
Fermentalg 13.38M
Adocia 3.85M
THX Pharma Société Anonyme 876.13K
MaaT Pharma 4.52M
Innate Pharma 9.01M
ABIONYX Pharma 4.10M
Nicox 3.32M
Revenue Rankings

OSE Immunotherapeutics News

More News